Familial cancer

Keyphrases

Publications

volume 23, number 3, 2024

Livia Archibugi, Fabio Casciani, Silvia Carrara, Erica Secchettin, Massimo Falconi, Gabriele Capurso, Salvatore Paiella
The Italian registry of families at risk for pancreatic cancer (IRFARPC): implementation and evolution of a national program for pancreatic cancer surveillance in high-risk individuals. Familial cancer 23 (3) (2024)
Amarensia Marit Spruitenburg, Hans Fa Vasen
The odyssee from surveillance to the detection of pancreatic cancer, total pancreatectomy, and its impact on life. insights from a p16-Leiden pathogenic variant carrier. Familial cancer 23 (3) (2024)
null Cristina-Marianini-Rios, María E Castillo Sanchez, Ana García García de Paredes, Mercedes Rodríguez, Emma Barreto, Jorge Villalón López, Raquel Fuentes, María Muñoz Beltrán, Alfonso Sanjuanbenito, Eduardo Lobo, Alejandra Caminoa, Ignacio Ruz-Caracuel, Sergio López Durán, José Ramón Foruny Olcina, Javier Blázquez, Enrique Vázquez Sequeros, Alfredo Carrato, Jose Carlos Martínez Ávila, Julie Earl
The best linear unbiased prediction (BLUP) method as a tool to estimate the lifetime risk of pancreatic ductal adenocarcinoma in high-risk individuals with no known pathogenic germline variants. Familial cancer 23 (3) (2024)
Michael J Pflüger, Lodewijk A A Brosens, Ralph H Hruban
Precursor lesions in familial and hereditary pancreatic cancer. Familial cancer 23 (3) (2024)
Michelle F Jacobs, Elena M Stoffel
Genetic and other risk factors for pancreatic ductal adenocarcinoma (PDAC). Familial cancer 23 (3) (2024)
Hiroyuki Matsubayashi, Chigusa Morizane
Familial and hereditary pancreatic cancer in Japan. Familial cancer 23 (3) (2024)
Aleksander M Bogdanski, Jeanin E van Hooft, Bas Boekestijn, Bert A Bonsing, Martin N J M Wasser, Derk C F Klatte, Monique E van Leerdam
Aspects and outcomes of surveillance for individuals at high-risk of pancreatic cancer. Familial cancer 23 (3) (2024)
J-Matthias Löhr, Daniel Öhlund, Emma Söreskog, Emil Andersson, Miroslav Vujasinovic, Niklas Zethraeus, Malin Sund
Can our experience with surveillance for inherited pancreatic cancer help to identify early pancreatic cancer in the general population? Familial cancer 23 (3) (2024)
Hans Fa Vasen, Marcia Irene Canto, Michael Goggins
Twenty-five years of surveillance for familial and hereditary pancreatic ductal adenocarcinoma: Historical perspectives and introduction to the special issue. Familial cancer 23 (3) (2024)
Hiroyuki Matsubayashi, Chigusa Morizane
Familial and hereditary pancreatic cancer in Japan. Familial cancer 23 (3) (2024)
Teresa A Brentnall
Familial pancreatic cancer: a long fruitful journey. Familial cancer 23 (3) (2024)
Anke M Onnekink, D C F Klatte, J E van Hooft, S H van den Berg, S M S van der Zwaan, R van Doorn, S C H Hinnen, T P Potjer, E M A Bleiker, M E van Leerdam
Attitudes toward genetic testing, family planning and preimplantation genetic testing in families with a germline CDKN2A pathogenic variant. Familial cancer 23 (3) (2024)
Michael Goggins
The role of biomarkers in the early detection of pancreatic cancer. Familial cancer 23 (3) (2024)
null Cristina-Marianini-Rios, María E Castillo Sanchez, Ana García García de Paredes, Mercedes Rodríguez, Emma Barreto, Jorge Villalón López, Raquel Fuentes, María Muñoz Beltrán, Alfonso Sanjuanbenito, Eduardo Lobo, Alejandra Caminoa, Ignacio Ruz-Caracuel, Sergio López Durán, José Ramón Foruny Olcina, Javier Blázquez, Enrique Vázquez Sequeros, Alfredo Carrato, Jose Carlos Martínez Ávila, Julie Earl
The best linear unbiased prediction (BLUP) method as a tool to estimate the lifetime risk of pancreatic ductal adenocarcinoma in high-risk individuals with no known pathogenic germline variants. Familial cancer 23 (3) (2024)
Hans Fa Vasen, Marcia Irene Canto, Michael Goggins
Twenty-five years of surveillance for familial and hereditary pancreatic ductal adenocarcinoma: Historical perspectives and introduction to the special issue. Familial cancer 23 (3) (2024)
Kasper Alexander Overbeek, Djuna L Cahen, Marco J Bruno
The role of endoscopic ultrasound in the detection of pancreatic lesions in high-risk individuals. Familial cancer 23 (3) (2024)
Aleksander M Bogdanski, Jeanin E van Hooft, Bas Boekestijn, Bert A Bonsing, Martin N J M Wasser, Derk C F Klatte, Monique E van Leerdam
Aspects and outcomes of surveillance for individuals at high-risk of pancreatic cancer. Familial cancer 23 (3) (2024)
Louise Wang, Rachel Levinson, Catherine Mezzacappa, Bryson W Katona
Review of the cost-effectiveness of surveillance for hereditary pancreatic cancer. Familial cancer 23 (3) (2024)
Julie Earl, Raquel Fuentes, María E Castillo Sanchez, Ana García García de Paredes, María Muñoz, Alfonso Sanjuanbenito, Eduardo Lobo, Alejandra Caminoa, Mercedes Rodríguez, Emma Barreto, Jorge Villalón López, Ignacio Ruz-Caracuel, Sergio López Durán, José Ramón Foruny Olcina, Bárbara Luna Sánchez, Sonia Camaño Páez, Ana Torres, Javier Blázquez, Enrique Vázquez Sequeros, Alfredo Carrato
The Spanish Familial Pancreatic Cancer Registry (PANGENFAM): a decade follow-up of individuals at high-risk for pancreatic cancer. Familial cancer 23 (3) (2024)
J-Matthias Löhr, Daniel Öhlund, Emma Söreskog, Emil Andersson, Miroslav Vujasinovic, Niklas Zethraeus, Malin Sund
Can our experience with surveillance for inherited pancreatic cancer help to identify early pancreatic cancer in the general population? Familial cancer 23 (3) (2024)
Elisabeth Maurer, Detlef K Bartsch
Surgical aspects related to hereditary pancreatic cancer. Familial cancer 23 (3) (2024)
Amarensia Marit Spruitenburg, Hans Fa Vasen
The odyssee from surveillance to the detection of pancreatic cancer, total pancreatectomy, and its impact on life. insights from a p16-Leiden pathogenic variant carrier. Familial cancer 23 (3) (2024)
Bas Boekestijn, Shirin Feshtali, Hans Vasen, Monique E van Leerdam, Bert A Bonsing, J Sven D Mieog, Martin N Wasser
Screening for pancreatic cancer in high-risk individuals using MRI: optimization of scan techniques to detect small lesions. Familial cancer 23 (3) (2024)
Hans Fa Vasen, Marcia Irene Canto, Michael Goggins
Twenty-five years of surveillance for familial and hereditary pancreatic ductal adenocarcinoma: Historical perspectives and introduction to the special issue. Familial cancer 23 (3) (2024)
Teresa A Brentnall
Familial pancreatic cancer: a long fruitful journey. Familial cancer 23 (3) (2024)
Hiroyuki Matsubayashi, Akiko Todaka, Takahiro Tsushima, Yoshimi Kiyozumi, Rina Harada, Eiko Ishihara, Satomi Higashigawa, Nobuyuki Ohike, Hiroki Sakamoto, Junya Sato, Hirotoshi Ishiwatari, Teichi Sugiura, Katsuhiko Uesaka
The response of pancreatic acinar cell carcinoma to platinum and olaparib therapy in a germline BRCA2 variant carrier: case report and literature review. Familial cancer 23 (3) (2024)
null Cristina-Marianini-Rios, María E Castillo Sanchez, Ana García García de Paredes, Mercedes Rodríguez, Emma Barreto, Jorge Villalón López, Raquel Fuentes, María Muñoz Beltrán, Alfonso Sanjuanbenito, Eduardo Lobo, Alejandra Caminoa, Ignacio Ruz-Caracuel, Sergio López Durán, José Ramón Foruny Olcina, Javier Blázquez, Enrique Vázquez Sequeros, Alfredo Carrato, Jose Carlos Martínez Ávila, Julie Earl
The best linear unbiased prediction (BLUP) method as a tool to estimate the lifetime risk of pancreatic ductal adenocarcinoma in high-risk individuals with no known pathogenic germline variants. Familial cancer 23 (3) (2024)
Bas Boekestijn, Shirin Feshtali, Hans Vasen, Monique E van Leerdam, Bert A Bonsing, J Sven D Mieog, Martin N Wasser
Screening for pancreatic cancer in high-risk individuals using MRI: optimization of scan techniques to detect small lesions. Familial cancer 23 (3) (2024)
J-Matthias Löhr, Daniel Öhlund, Emma Söreskog, Emil Andersson, Miroslav Vujasinovic, Niklas Zethraeus, Malin Sund
Can our experience with surveillance for inherited pancreatic cancer help to identify early pancreatic cancer in the general population? Familial cancer 23 (3) (2024)
Nicolette Juliana Rodriguez, Sapna Syngal
Expanding access to genetic testing for pancreatic cancer. Familial cancer 23 (3) (2024)
Louise Wang, Rachel Levinson, Catherine Mezzacappa, Bryson W Katona
Review of the cost-effectiveness of surveillance for hereditary pancreatic cancer. Familial cancer 23 (3) (2024)
Anke M Onnekink, D C F Klatte, J E van Hooft, S H van den Berg, S M S van der Zwaan, R van Doorn, S C H Hinnen, T P Potjer, E M A Bleiker, M E van Leerdam
Attitudes toward genetic testing, family planning and preimplantation genetic testing in families with a germline CDKN2A pathogenic variant. Familial cancer 23 (3) (2024)
Elisabeth Maurer, Detlef K Bartsch
Surgical aspects related to hereditary pancreatic cancer. Familial cancer 23 (3) (2024)
Michael Goggins
The role of biomarkers in the early detection of pancreatic cancer. Familial cancer 23 (3) (2024)
Elisabeth Maurer, Detlef K Bartsch
Surgical aspects related to hereditary pancreatic cancer. Familial cancer 23 (3) (2024)
Amarensia Marit Spruitenburg, Hans Fa Vasen
The odyssee from surveillance to the detection of pancreatic cancer, total pancreatectomy, and its impact on life. insights from a p16-Leiden pathogenic variant carrier. Familial cancer 23 (3) (2024)
Kasper Alexander Overbeek, Djuna L Cahen, Marco J Bruno
The role of endoscopic ultrasound in the detection of pancreatic lesions in high-risk individuals. Familial cancer 23 (3) (2024)
Bas Boekestijn, Shirin Feshtali, Hans Vasen, Monique E van Leerdam, Bert A Bonsing, J Sven D Mieog, Martin N Wasser
Screening for pancreatic cancer in high-risk individuals using MRI: optimization of scan techniques to detect small lesions. Familial cancer 23 (3) (2024)
Anke M Onnekink, D C F Klatte, J E van Hooft, S H van den Berg, S M S van der Zwaan, R van Doorn, S C H Hinnen, T P Potjer, E M A Bleiker, M E van Leerdam
Attitudes toward genetic testing, family planning and preimplantation genetic testing in families with a germline CDKN2A pathogenic variant. Familial cancer 23 (3) (2024)
Hans Fa Vasen, Marcia Irene Canto, Michael Goggins
Twenty-five years of surveillance for familial and hereditary pancreatic ductal adenocarcinoma: Historical perspectives and introduction to the special issue. Familial cancer 23 (3) (2024)
Julie Earl, Raquel Fuentes, María E Castillo Sanchez, Ana García García de Paredes, María Muñoz, Alfonso Sanjuanbenito, Eduardo Lobo, Alejandra Caminoa, Mercedes Rodríguez, Emma Barreto, Jorge Villalón López, Ignacio Ruz-Caracuel, Sergio López Durán, José Ramón Foruny Olcina, Bárbara Luna Sánchez, Sonia Camaño Páez, Ana Torres, Javier Blázquez, Enrique Vázquez Sequeros, Alfredo Carrato
The Spanish Familial Pancreatic Cancer Registry (PANGENFAM): a decade follow-up of individuals at high-risk for pancreatic cancer. Familial cancer 23 (3) (2024)
Michael Goggins
The role of biomarkers in the early detection of pancreatic cancer. Familial cancer 23 (3) (2024)
Kasper Alexander Overbeek, Djuna L Cahen, Marco J Bruno
The role of endoscopic ultrasound in the detection of pancreatic lesions in high-risk individuals. Familial cancer 23 (3) (2024)
Aleksander M Bogdanski, Jeanin E van Hooft, Bas Boekestijn, Bert A Bonsing, Martin N J M Wasser, Derk C F Klatte, Monique E van Leerdam
Aspects and outcomes of surveillance for individuals at high-risk of pancreatic cancer. Familial cancer 23 (3) (2024)
Anke M Onnekink, D C F Klatte, J E van Hooft, S H van den Berg, S M S van der Zwaan, R van Doorn, S C H Hinnen, T P Potjer, E M A Bleiker, M E van Leerdam
Attitudes toward genetic testing, family planning and preimplantation genetic testing in families with a germline CDKN2A pathogenic variant. Familial cancer 23 (3) (2024)
Hiroyuki Matsubayashi, Akiko Todaka, Takahiro Tsushima, Yoshimi Kiyozumi, Rina Harada, Eiko Ishihara, Satomi Higashigawa, Nobuyuki Ohike, Hiroki Sakamoto, Junya Sato, Hirotoshi Ishiwatari, Teichi Sugiura, Katsuhiko Uesaka
The response of pancreatic acinar cell carcinoma to platinum and olaparib therapy in a germline BRCA2 variant carrier: case report and literature review. Familial cancer 23 (3) (2024)
Julie Earl, Raquel Fuentes, María E Castillo Sanchez, Ana García García de Paredes, María Muñoz, Alfonso Sanjuanbenito, Eduardo Lobo, Alejandra Caminoa, Mercedes Rodríguez, Emma Barreto, Jorge Villalón López, Ignacio Ruz-Caracuel, Sergio López Durán, José Ramón Foruny Olcina, Bárbara Luna Sánchez, Sonia Camaño Páez, Ana Torres, Javier Blázquez, Enrique Vázquez Sequeros, Alfredo Carrato
The Spanish Familial Pancreatic Cancer Registry (PANGENFAM): a decade follow-up of individuals at high-risk for pancreatic cancer. Familial cancer 23 (3) (2024)
Livia Archibugi, Fabio Casciani, Silvia Carrara, Erica Secchettin, Massimo Falconi, Gabriele Capurso, Salvatore Paiella
The Italian registry of families at risk for pancreatic cancer (IRFARPC): implementation and evolution of a national program for pancreatic cancer surveillance in high-risk individuals. Familial cancer 23 (3) (2024)
Louise Wang, Rachel Levinson, Catherine Mezzacappa, Bryson W Katona
Review of the cost-effectiveness of surveillance for hereditary pancreatic cancer. Familial cancer 23 (3) (2024)
Michelle F Jacobs, Elena M Stoffel
Genetic and other risk factors for pancreatic ductal adenocarcinoma (PDAC). Familial cancer 23 (3) (2024)